|
CKAP5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.430000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.697700E-02 |
| Normal-vs-Stage2 |
1.428790E-01 |
| Normal-vs-Stage3 |
2.850200E-02 |
| Normal-vs-Stage4 |
3.531600E-01 |
| Stage1-vs-Stage2 |
9.746200E-01 |
| Stage1-vs-Stage3 |
4.935000E-01 |
| Stage1-vs-Stage4 |
3.258100E-02 |
| Stage2-vs-Stage3 |
6.773800E-01 |
| Stage2-vs-Stage4 |
6.450200E-02 |
| Stage3-vs-Stage4 |
1.936190E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.315970E-01 |
| Normal-vs-AfricanAmerican |
1.987700E-02 |
| Normal-vs-Asian |
2.364400E-01 |
| Caucasian-vs-AfricanAmerican |
1.795410E-01 |
| Caucasian-vs-Asian |
1.736810E-01 |
| AfricanAmerican-vs-Asian |
5.058200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.817700E-02 |
| Normal-vs-Female |
2.678000E-01 |
| Male-vs-Female |
4.704400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.366400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.108800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.221800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.401560E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.802800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.551800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.748850E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.402400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.172440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.820400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.569800E-01 |
| Normal-vs-Grade 2 |
2.114400E-02 |
| Normal-vs-Grade 3 |
2.537900E-02 |
| Normal-vs-Grade 4 |
2.268400E-01 |
| Grade 1-vs-Grade 2 |
1.434640E-01 |
| Grade 1-vs-Grade 3 |
1.706210E-01 |
| Grade 1-vs-Grade 4 |
4.849000E-01 |
| Grade 2-vs-Grade 3 |
7.702400E-01 |
| Grade 2-vs-Grade 4 |
1.603760E-02 |
| Grade 3-vs-Grade 4 |
1.300410E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.357550E-02 |
| Normal-vs-ccB subtype |
6.682400E-01 |
| ccA subtype-vs-ccB subtype |
4.795700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.406770E-01 |
| Normal-vs-N1 |
2.628800E-01 |
| N0-vs-N1 |
5.945900E-02 |
|
|
